Zurich Cantonal Bank’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
JT
RCM
DTC
Zurich Cantonal Bank's PCVX Position: Q2 2026 in Review
Zurich Cantonal Bank increased its Vaxcyte (PCVX) stake by 17% in Q2 2026, buying an estimated $414K and bringing the position to 53,198 shares worth $3.09M. The position accounts for 0.01% of the portfolio, ranked #906.
Zurich Cantonal Bank first reported a position in PCVX in Q1 2022 and has held it in 18 quarters since. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.
- Zurich Cantonal Bank held 53,198 shares of Vaxcyte worth $3.09M as of Q2 2026.
- Zurich Cantonal Bank bought 7,630 Vaxcyte shares in Q2 2026, an estimated $414K.
- Vaxcyte made up 0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #906 holding.
- Zurich Cantonal Bank first reported a position in Vaxcyte in Q1 2022 and has held it in 18 quarters since.
- 331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.
Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.